371 related articles for article (PubMed ID: 19501008)
1. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
Peters L; McCarthy AE; Faught C
Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
[TBL] [Abstract][Full Text] [Related]
2. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
[TBL] [Abstract][Full Text] [Related]
3. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
[TBL] [Abstract][Full Text] [Related]
6. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
7. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.
Porto MA; Alcântara LM; Leal M; Castro N; Carvalho EM
Am J Trop Med Hyg; 2005 Feb; 72(2):124-5. PubMed ID: 15741545
[TBL] [Abstract][Full Text] [Related]
8. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
Einsiedel L; Fernandes L
Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
Arch EL; Schaefer JT; Dahiya A
Dermatol Online J; 2008 Dec; 14(12):6. PubMed ID: 19265619
[TBL] [Abstract][Full Text] [Related]
10. Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1).
Lambertucci JR; Leão FC; Barbosa AJ
Rev Soc Bras Med Trop; 2003; 36(4):541-2. PubMed ID: 12937738
[No Abstract] [Full Text] [Related]
11. Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area.
Dixon AC; Yanagihara ET; Kwock DW; Nakamura JM
West J Med; 1989 Oct; 151(4):410-3. PubMed ID: 2588581
[TBL] [Abstract][Full Text] [Related]
12. Strongyloides hyperinfection following hematopoietic stem cell transplant in a patient with HTLV-1-associated T-cell leukemia.
Alpern JD; Arbefeville SS; Vercellotti G; Ferrieri P; Green JS
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27860061
[TBL] [Abstract][Full Text] [Related]
13. A Canadian immigrant with coinfection of Strongyloides stercoralis and human T-lymphotropic virus 1.
Lagacé-Wiens PR; Harding GK
CMAJ; 2007 Aug; 177(5):451-3. PubMed ID: 17724322
[No Abstract] [Full Text] [Related]
14. [Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate].
Freites A
Invest Clin; 2008 Dec; 49(4):455-6. PubMed ID: 19245164
[TBL] [Abstract][Full Text] [Related]
15. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
Segarra-Newnham M
Ann Pharmacother; 2007 Dec; 41(12):1992-2001. PubMed ID: 17940124
[TBL] [Abstract][Full Text] [Related]
16. Periumbilical purpura: challenge and answer. Diagnosis: Strongyloides stercoralis hyperinfection.
Osio A; Demongeot C; Battistella M; Lhuillier E; Zafrani L; Vignon-Pennamen MD
Am J Dermatopathol; 2014 Nov; 36(11):899-900, 907. PubMed ID: 25343211
[No Abstract] [Full Text] [Related]
17. Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection.
Jeyamani R; Joseph AJ; Chacko A
Trop Gastroenterol; 2007; 28(4):176-7. PubMed ID: 18416349
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan.
Toma H; Sato Y; Shiroma Y; Kobayashi J; Shimabukuro I; Takara M
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):147-51. PubMed ID: 11023084
[TBL] [Abstract][Full Text] [Related]
19. Strongyloidiasis presenting as duodenal obstruction in a patient infected with human T-cell lymphotropic virus type 1.
Hindy P; Parvin R; Hanna K; Gress F
Gastrointest Endosc; 2011 Aug; 74(2):439-41. PubMed ID: 21704987
[No Abstract] [Full Text] [Related]
20. Acute respiratory distress syndrome due to Strongyloides stercoralis in non-Hodgkin's lymphoma.
Vigg A; Mantri S; Reddy VA; Biyani V
Indian J Chest Dis Allied Sci; 2006; 48(1):67-9. PubMed ID: 16482955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
